Navigation Links
American Academy of Dermatology: How You Feel on the Inside Could be Affecting How You Look on the Outside
Date:11/13/2008

Dermatologists can help minimize the effects of stress and emotions on

skin, hair and nails

NEW YORK, Nov. 13 /PRNewswire/ -- In the emotional rollercoaster of life, sometimes the "down" periods have long-lasting effects on more than just our mood. In fact, numerous studies link factors that impact our emotional well-being -- such as stress, depression and anxiety -- to an increase in skin, hair or nail problems. Now, dermatologists are advising patients to recognize these secondary symptoms and to seek treatment early before they cause additional stress.

Speaking today at the American Academy of Dermatology's skin academy (Academy), dermatologist and clinical psychologist Richard G. Fried, MD, PhD, FAAD, of Yardley, Pa., discussed the reciprocal relationship between feelings and appearance, and how failing to address these concerns can affect how we look, feel and function.

"When patients are going through a rough period in their lives, negative emotions can wreak havoc on their appearance," said Dr. Fried. "So, as a result, patients might start to notice that their hair is thinning, their skin is inflamed or their nails are brittle -- which can be physical manifestations of their mental state. These unwanted physical changes can have a profoundly negative impact on how they feel. The negative emotions can trigger a vicious cycle of worsening skin, hair and nails leading to worsening of their emotional state and can lead to further worsening of the skin problem. Dermatologists can play a key role in helping patients not only alleviate these physical symptoms, but also help enhance their quality of life during a difficult time."

Psychodermatology Interventions

Stress can manifest itself on one's appearance in many ways, primarily by making the skin more sensitive and more reactive. For example, Dr. Fried noted that stress can make rosacea more red, result in acne lesions that are more inflamed an
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmacyChecker.com Publishes Safe Strategies for Drug Savings to Help All Americans Get Affordable Medication
2. Research demonstrates differing genetic makeup of lung cancer in African-American patients
3. Quitting Smoking Saves Lives and Money: New American Lung Association Report Finds Most States Failing to Adequately Protect Residents and Their Bottom Line
4. Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging on the Release of Sen. Baucuss Health Care Reform Proposal
5. Experts at American Society for Reproductive Medicine (ASRM) Satellite Symposium Reach Consensus: Better Intimacy = Better Overall Well-Being
6. Fear, misconceptions about screenings keep many African-Americans from getting mammograms
7. Regence Honored by American Heart Association as a Start! Fit-Friendly Company
8. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
9. Idea to Arm Cancer Patients with Information Specific to Their Disease and Treatment Receives Nod, Grant from American Cancer Society
10. American Lung Association of Nevada Receives $150,000 Grant from Anthem Blue Cross and Blue Shield Foundation to Help Nevadas Youth Stay Smoke-Free
11. American Red Cross of Greater Los Angeles Named Outstanding Volunteer Organization
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3